Veterinary Medicines

Vanguard Plus 7 liofilizāts un šķīdinātājs šķīduma injekcijām pagatavošanai suņiem

Authorised
  • Canine distemper virus, strain N-CDV, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine parvovirus, strain NL-35-D, Live
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
Download as PDF

Product identification

Medicine name:
Vanguard Plus 7 liofilizāts un šķīdinātājs šķīduma injekcijām pagatavošanai suņiem
Active substance:
  • Canine distemper virus, strain N-CDV, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine parvovirus, strain NL-35-D, Live
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain N-CDV, Live
    1000.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Canine adenovirus 2, strain Manhattan, Live
    1584.89
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Canine parainfluenza virus, strain NL-CPI-5, Live
    1000000.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Canine parvovirus, strain NL-35-D, Live
    10000000.00
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
    40.00
    Protective Dose
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
    40.00
    Protective Dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Available in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/03/1610
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 11/12/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 11/12/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 11/12/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."